Small molecules which reverse Arsenic treatment
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00013261
TitleSmall molecules which reverse Arsenic treatment
DescriptionThe L1000 database was queried in order to identify small molecule perturbations which reverse the gene expression signature induced by Arsenic treatment in the HepG2 - liver carcinoma cells cell type.
Analysis URLhttp://amp.pharm.mssm.edu/L1000CDS2/#/result/58d1de3ae467bea600fb92e6
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis Curatorcadimo
CREEDS IDdrug:3529
Cell TypeHepG2 - liver carcinoma cells
Drug NameArsenic
Organismhuman
PubChem CID5359596
SMILES ID[As]
L1000CDS2 parameters
Directionreverse
Characteristic Direction parameters
Control SamplesGSM159303, GSM159305, GSM159306
Perturbed SamplesGSM159312, GSM159314, GSM159315
Tools used in the analysis
Dataset Accession
L1000CDS2
Published August 2016
An ultra-fast LINCS L1000 Characteristic Direction signature search engine
7756
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
Datasets used in the analysis
Keyword
Tool Name
GSE6907
Gene Expression Omnibus
Heavy metals effect on liver cell line
56
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.